Market
Study shows 50%+ improvement in mobility with hypothalamus stimulation by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Published study in a peer-reviewed medical journal
Story
Swiss Researchers Use Hypothalamus Stimulation and Implants to Restore Walking in Paralysed Patients
Dec 2, 2024, 07:03 PM
Swiss researchers have achieved a breakthrough in spinal cord injury rehabilitation by using deep brain stimulation (DBS) targeting the lateral hypothalamus. The study, published in Nature Medicine and conducted by researchers from EPFL and Lausanne University Hospital, enabled two partially paralysed patients to regain the ability to walk short distances and climb stairs. This pioneering technique, involving electrode implants, activates residual neural connections, promoting recovery of lower limb movements. The findings were validated in preclinical models involving mice and rats, as well as in a first-in-human feasibility study. The research highlights the potential of DBS as a transformative therapy for spinal cord injuries.
View original story
Similar markets
Partial improvement (e.g., short distances) • 25%
No improvement • 25%
Significant improvement (e.g., walking long distances) • 25%
Full mobility restoration • 25%
71% to 90% • 25%
More than 90% • 25%
Less than 50% • 25%
50% to 70% • 25%
Full mobility restoration in a patient • 25%
None of the above • 25%
FDA approval • 25%
Widespread clinical trials • 25%
No • 50%
Yes • 50%
Other • 25%
Improvement in speech • 25%
Restoration of hand movement • 25%
Restoration of leg movement • 25%
No • 50%
Yes • 50%
United States • 25%
Other • 25%
Switzerland • 25%
European Union • 25%
Cleveland Clinic • 25%
Other • 25%
Mayo Clinic • 25%
Johns Hopkins Hospital • 25%
